C-type natriuretic peptide regulates cellular condensation and glycosaminoglycan synthesis during chondrogenesis

Endocrinology

Volumn 148, Issue 10, 2007, Pages 5030-5041

  Woods, Anita ^a   Khan, Sameena ^a   Beier, Frank ^a,b  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; NATRIURETIC PEPTIDE TYPE C; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9;

ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; CELL ACTIVITY; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; EMBRYO; ENCHONDRAL OSSIFICATION; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCAN METABOLISM; LIMB BUD; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; STEM CELL;

ANIMALS; CADHERINS; CHONDROCYTES; CHONDROGENESIS; CYCLIC GMP; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; GLYCOSAMINOGLYCANS; HIGH MOBILITY GROUP PROTEINS; MICE; MICE, INBRED STRAINS; NATRIURETIC PEPTIDE, C-TYPE; PENTOSYLTRANSFERASES; PROTEOGLYCANS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 34748846796     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0695     Document Type: Article

References (56)

1. Rosenzweig A, Seidman CE 1991 Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 60:229-255
2. Hagiwara H, Sakaguchi H, Itakura M, Yoshimoto T, Furuya M, Tanaka S, Hirose S 1994 Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J Biol Chem 269:10729-10733
3. Suda M, Ogawa Y, Tanaka K, Yasoda A, Takigawa T, Uehira M, Nishimoto H, Itoh H, Saito Y, Shiota K, Nakao K 1998 Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci USA 95:2337-2342
4. Tamura N, Garbers DL 2003 Regulation of the guanylyl cyclase-B receptor by alternative splicing. J Biol Chem 278:48880-48889
5. Komatsu Y, Chusho H, Tamura N, Yasoda A, Miyazawa T, Suda M, Miura M, Ogaway Y, Nakao K 2002 Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice. J Bone Miner Res 20:331-336
6. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, Itoh H, Tanaka K, Saito Y, Katsuki M, Nakao K 2001 Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci USA 98:4016-4021
7. Bartels CF, Bukulmez H, Padayatii P, Rhee DK, van Ravenswaij-Arts C, Pauli RM, Mundlos S, Chitayat D, Shih LY, Al-Gazali LI, Kant S, Cole T, Morton J, Cormier-Daire V, Faivre L, Kirk J, Mortier GR, Leroy J, Zabel B, Kim CA, Crow Y, Braveman NE, van den Akker F, Warman ML 2004 Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet 75:27-34
8. Olney RC, Bukulmez H, Bartels CF, Prickett TC, Espiner EA, Potter LR, Warman ML 2006 Heterozygous mutations in natriuretic peptide-B (NPR2) are associated with short stature. J Clin Endocrinal Metab 91:1229-1232
9. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M, Tamura N, Ogawa Y, Nakao K 2004 Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10:80-86
10. Potter LR, Abbey-Hosch S, Dickey DM 2006 Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signalling functions. Endocr Rev 27:47-72
11. Agoston H, Khan S, James CG, Gillespie JR, Serra R, Stanton LA, Beier F 2007 C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways. BMC Dev Biol 7:18
12. Mericq V, Uyeda JA, Barnes KM, De Luca F, Baron J 2000 Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP. Pediatr Res 47:189-193
13. Fuishige K, Kotera J, Yanaka N, Akatsuka H, Omori K 1999 Alteration of cGMP metabolism during chondrogenic differentiation of chondroprogenitor-like EC cells, ATDC5. Biochim Biophys Acta 1452:219-227
14. Kronenberg HM 2003 Developmental regulation of the growth plate. Nature 423:332-336
15. Hall BK, Miyake T 2000 All for one and one for all: Condensations and the initiation of skeletal development. Bioessays 22:138-147
16. Ahrens PB, Solursh M, Reiters R 1977 Stage-related capacity for limb chondrogenesis in cell culture. Dev Biol 60:69-82
17. Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R 1995 Toward a molecular understanding of skeletal development. Cell 80:371-378
18. Oberlender SA, Tuan RS 1994 Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development 120:177-187
19. DeLise AM, Tuan RS 2002 Analysis of N-cadherin function in limb mesenchymal chondrogenesis in vitro. Dev Dynam 225:195-204
20. Tavella S, Raffo P, Tacchetti C, Cancedda R, Castagnola P 1994 N-CAM and N-cadherin expression during in vitro chondrogenesis. Exp Cell Res 215:354-362
21. Fang J, Hall BK 1999 N-CAM is not required for initiation of secondary chondrogenesis: the role of N-CAM in skeletal condensation and differentiation. Int J Dev Biol 43:335-342
22. Tuan RS 2004 Biology of developmental and regenerative skeletogenesis. Clin Orthop Relat Res 427:S105-S117
23. Muir H 1995 The chondrocyte, architecture of cartilage, biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 17:1039-1048
24. Mwale F, Tchetina E, Wu CW, Poole AR 2002 The assembly and remodeling of the extracellular matrix in the growth plate in relationship to mineral deposition and cellular hypertrophy: an in situ study of collagens II and IX and proteoglycan. J Bone Miner Res 2:275-283
25. Bi W, Huang W, Whitworth DJ, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B 2001 Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization Proc Natl Acad Sci USA 98:6698-6703
26. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B 1999 Sox9 is required for cartilage formation. Nat Genet 22:85-89
27. Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, Ling KW, Sham MW, Koopman P, Tam PP, Cheah KS 1997 SOX9 directly regulates the type-ll collagen gene. Nat Genet 16:174-178
28. Sekiya I, Tsuji K, Koopman P, Wantanabe H, Yamada Y, Shinomiya K, Nifuji A, Noda M 2000 Sox9 enhances aggrecan promoter/enhancer activity and is upregulated by retinoic acid in a cartilage derived cell-line TC6. J Biol Chem 275:10738-10744
29. Lefebvre V, Li P, de Crombrugghe B 1998 A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17:5718-5733
30. Doege KJ 1999 Aggrecan. In: Kreis T, Vale R, eds. Guidebook to the extracellular matrix, anchor and adhesion proteins. 2nd ed. Oxford, UK: Oxford University Press (a Sambrook and Tooze Publication); 359-361
31. Bruckner P, van der Rest M 1994 Structure and function of cartilage collagens. Microsc Res Tech 28:378-384
32. Maleski MP, Knudson CB 1996 Hyaluronan-mediated aggregation of limb bud mesenchyme and mesenchymal condensation during chondrogenesis. Exp Cell Res 225:55-66
33. Kimura JH, Hardingham TE, Hascall VC 1980 Assembly of newly synthesized proteoglycan and link protein into aggregates in cultures of chondrosarcoma chondrocytes. J Biol Chem 255:7134-7143
34. Watanabe H, Yamada Y, Kimata K 1998 Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. J Biochem 124:687-693
35. Terry DE, Chopra RK, Ovenden J, Anastassiades TP 2000 Differential uses of Alcian blue and toluidine blue dyes for the quantification and isolation of anionic glycoconjugates from cell cultures: application to proteoglycans and a high-molecular-weight glycoprotein synthesized by articular chondrocytes. Anal Biochem 285:211-219
36. Krueger RC, Fields TA, Hildreth J, Schwartz NB 1990 Chick cartilage chondroitin sulfate proteoglycan core protein. I. Generation and characterization of peptides and specificity for glycosaminoglycan attachment. J Biol Chem 265:12075-12087
37. Iozzo RV 1998 Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67:609-652
38. Keiser H, Shulman HJ, Sandson JI 1972 Immunochemistry of cartilage proteoglycan. Immunodiffusion and gel-electrophoretic studies. Biochem J 126:163-169
39. Kearns AE, Vertel BM, Schwartz NB 1993 Topography of glycosylation and UDP-xylose production. J Biol Chem 268:11097-11104
40. Woods A, Wang G, Dupuis H, Shao Z, Beier F 14 June 2007 Rac1 signaling stimulates N-cadherin expression, mesenchymal condensation and chondrogenesis. J Biol Chem 10.1074/jbc.M700680200
41. Cuellar K, Chuong H, Hubbell SM, Hinsdale ME 2006 Biosynthesis of chondroitin and heparan sulfate in CHO cells depends on xylosyltransferase II. J Biol Chem 282:5195-5200
42. Prante C, Bieback K, Funke C, Schon S, Kern S, Kuhn J, Gastens M, Kleesiek K, Gotting C 2006 The formation of extracellular matrix during chondrogenic differentiation of mesenchymal stem cells correlates with increased levels of xylosyltransferase I. Stem Cells 24:2252-2261
43. Habuchi O 2000 Diversity and functions of glycosaminoglycan sulfotransferases. Biochim Biophys Acta 1474:115-127
44. Sugahara K, Kitagawa H 2000 Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr Opin Cell Biol 10:518-527
45. Herndon ME, Lander AD 1990 A diverse set of developmentally regulated proteoglycans is expressed in the rat central nervous system. Neuron 4:949-961
46. Theile H, Sakano M, Kitagawa H, Sugahara K, Rajab A, Hohne W, Ritter H, Leschik G, Nurnberg P, Mundlos S 2004 Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement. Proc Natl Acad Sci USA 101:10155-10160
47. Kluppel M, Wight TN, Chan C, Hinek A, Wrana JL 2005 Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis. Development 132:3989-4003
48. Stanton LA, Sabari S, Sampaio AV, Underhill TM, Beier F 2004 p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. Biochem J 378:53-62
49. Woods A, Wang G, Beier F 2005 RhoA/ROCK signaling regulates Sox9 expression and actin organization during chondrogenesis. J Biol Chem 280:11626-11634
50. Weston AD, Chandraratna RAS, Torchia J, Underhill TM 2002 Requirement for RAR-mediated gene repression in skeletal progenitor differentiation. J Cell Biol 158:39-51
51. Lefebvre V, Smits P 2005 Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 75:200-212
52. Rossi A, Superti-Furga A 2001 Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance. Hum Mutat 17:159-171
53. Hastbacka J, Superti-Furga A, Wilcox WR, Rimoin DL, Cohn DH, Lander ES 1996 Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias. Am J Hum Genet 58:255-262
54. Koziel L, Kunath M, Kelly OG, Vortkamp A 2004 Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification. Developmental Cell 6:801-813
55. Crown SE, Sweeney MD, Leary JA, Handel TM 2006 Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding. J Biol Chem 281:25438-25446
56. Osses N, Gutierrez J, Lopez-Rovira T, Ventura F, Brandan E 2006 Sulfation is required for bone morphogenetic protein 2-dependent ID1 induction. Biochem Biophys Res Commun 344:1207-1215